Screener
Axsome Therapeutics AXSM Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accounts receivable, net | 251,062 | 224,464 |
| Inventories, net | 31,515 | 27,938 |
| Prepaid and other current assets | 23,523 | 13,651 |
| Total current assets | 611,206 | 588,986 |
| Equipment, net | 567 | 562 |
| Right-of-use asset - operating lease | 20,014 | 20,858 |
| Goodwill | 12,042 | 12,042 |
| Intangible asset, net | 38,947 | 40,519 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Axsome Therapeutics's total current assets?
- Axsome Therapeutics (AXSM) reported total current assets of $611.21M in Q1 2026.
- How has Axsome Therapeutics's total current assets changed year-over-year?
- Axsome Therapeutics's total current assets increased by 23.6% year-over-year, from $494.63M to $611.21M.
- What is the long-term trend for Axsome Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Axsome Therapeutics's total current assets has grown at a 26.2% compound annual growth rate (CAGR), from $184.02M to $588.99M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Axsome Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude